Alexey Shamov, Head of Marketing for Industry Solutions at SIBUR, commented:
“We first developed these polymers to meet demand in the Russian healthcare market. Now, in response to increasing global demand for medical-grade polymers in various countries, driven by growth in healthcare, we have added them to our export portfolio as well.”
Initial testing of SIBUR’s medical-grade polymers in Egypt has demonstrated that they meet the specified characteristics and are now approved for packaging for infusion solutions. SIBUR is currently in negotiations to supply this product to various pharmaceutical producers in Egypt on a regular basis.
Samples of SIBUR’s medical-grade polymers are presently undergoing testing in China, Kenya, Saudi Arabia and the United Arab Emirates. Tests are also scheduled to take place in Pakistan, Turkey and Vietnam.
Hashtag: #SIBUR
The issuer is solely responsible for the content of this announcement.
Key takeaways:Kumaraswamy warned that Congress could push DK Shivakumar out as chief minister.DK Shivakumar’s claim…
Key takeaways:Nana Patekar has officially been cast in Nagraj Manjule's upcoming Marathi film Khashaba.All three…
Key takeaways:Zoho announced no annual pay hikes for 2024, citing rising AI and server costs.Founder…
Key takeaways:The INDIA bloc filed a Supreme Court petition challenging voter deletions made under the…
Key takeaways:Immigration agents searched Rep. Ilhan Omar’s Washington home as part of a criminal probe.Omar…
Key takeaways:Jamie Carragher publicly urged Liverpool to drop Florian Wirtz, calling the £116 million signing a…